MIT License

License text

MIT License

Copyright (c) 2025–2026 BioValue contributors

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.

What this means in practice

You can use BioValue in commercial work, modify the engine for your firm’s internal models, fork it on GitHub, or embed it in another product. The only obligations are to preserve the copyright notice and the license text in any copies or substantial portions you redistribute.

The “AS IS” clause is important: BioValue is a research and analytical tool, not investment advice. The model produces estimates based on stated assumptions; real-world deal outcomes depend on factors the model does not capture (private information, strategic premiums, integration costs, regulatory surprises). Treat output as a starting point for diligence, not as a decision.

Full license file

The canonical text of the MIT License is also available at opensource.org/licenses/MIT.